376 related articles for article (PubMed ID: 16008823)
41. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
42. Selective metabolism of kynurenine in the spleen in the absence of indoleamine 2,3-dioxygenase induction.
Espey MG; Namboodiri MA
Immunol Lett; 2000 Jan; 71(1):67-72. PubMed ID: 10709788
[TBL] [Abstract][Full Text] [Related]
43. Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice.
Lehrmann E; Guidetti P; Löve A; Williamson J; Bertram EH; Schwarcz R
Epilepsia; 2008; 49 Suppl 2():13-23. PubMed ID: 18226168
[TBL] [Abstract][Full Text] [Related]
44. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity.
Lopes KO; Sparks DL; Streit WJ
Glia; 2008 Aug; 56(10):1048-60. PubMed ID: 18442088
[TBL] [Abstract][Full Text] [Related]
45. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
[TBL] [Abstract][Full Text] [Related]
46. [Estrogen receptor alpha and colocalization of Bcl-2 in hippocampus of Alzheimer's disease].
Zeng M; Lu YP; Xu H; Zhou JN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):108-11. PubMed ID: 15171543
[TBL] [Abstract][Full Text] [Related]
47. Increased quinolinic acid in peripheral mononuclear cells in Alzheimer's dementia.
Busse M; Hettler V; Fischer V; Mawrin C; Hartig R; Dobrowolny H; Bogerts B; Frodl T; Busse S
Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):493-500. PubMed ID: 28386767
[TBL] [Abstract][Full Text] [Related]
48. Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid.
Reinhard JF
Neurochem Res; 1998 May; 23(5):661-5. PubMed ID: 9566604
[TBL] [Abstract][Full Text] [Related]
49. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE
Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843
[TBL] [Abstract][Full Text] [Related]
50. The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains.
Bernstein HG; Blazejczyk M; Rudka T; Gundelfinger ED; Dobrowolny H; Bogerts B; Kreutz MR; Kuznicki J; Wojda U
Neuropathol Appl Neurobiol; 2005 Jun; 31(3):314-24. PubMed ID: 15885068
[TBL] [Abstract][Full Text] [Related]
51. Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques.
Saito K; Lackner A; Markey SP; Heyes MP
Brain Res; 1991 Feb; 540(1-2):353-6. PubMed ID: 1647247
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
[TBL] [Abstract][Full Text] [Related]
53. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ
J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905
[TBL] [Abstract][Full Text] [Related]
54. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
55. Expression of the kynurenine pathway enzymes in human microglia and macrophages.
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ
Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722
[TBL] [Abstract][Full Text] [Related]
56. Neuronal expression of vimentin in the Alzheimer's disease brain may be part of a generalized dendritic damage-response mechanism.
Levin EC; Acharya NK; Sedeyn JC; Venkataraman V; D'Andrea MR; Wang HY; Nagele RG
Brain Res; 2009 Nov; 1298():194-207. PubMed ID: 19728994
[TBL] [Abstract][Full Text] [Related]
57. Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.
Choei H; Sasaki N; Takeuchi M; Yoshida T; Ukai W; Yamagishi S; Kikuchi S; Saito T
Acta Neuropathol; 2004 Sep; 108(3):189-93. PubMed ID: 15221334
[TBL] [Abstract][Full Text] [Related]
58. Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis.
Zhang Y; Kang SA; Mukherjee T; Bale S; Crane BR; Begley TP; Ealick SE
Biochemistry; 2007 Jan; 46(1):145-55. PubMed ID: 17198384
[TBL] [Abstract][Full Text] [Related]
59. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
60. Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons.
Patil S; Sheng L; Masserang A; Chan C
Neurosci Lett; 2006 Oct; 406(1-2):55-9. PubMed ID: 16904262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
